Allergan Reports Fourth-Quarter 2019 Results That Plow Past Expectations

Shares of Allergan (NYSE: AGN) received a slight bump on Monday morning in response to a fourth-quarter earnings report that exceeded expectations on the top and bottom lines. Shares of AbbVie (NYSE: ABBV), a larger drugmaker with plans to buy Allergan in the first quarter, also ticked up slightly.

Allergan's total revenue climbed 6.6% to $4.35 billion, which was 6% more than analysts' average expectation. On the bottom line, adjusted earnings exceeded consensus estimates by 13% and reached $5.22 per share.

Image source: Getty Images.

Continue reading

Source Fool.com